News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Dr. Reddy’s Laboratories Ltd. Announces Five ANDA Approvals and Generic Product Launches in the US Market
February 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched the following five products in the US market during the month of January:
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
MORE ON THIS TOPIC
Complete response letters
Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
April 23, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA issues warning letter after GLP-1 manufacturer refuses inspectors access
April 22, 2026
·
2 min read
·
Nick Paul Taylor
Podcast
Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
April 22, 2026
·
1 min read
·
Heather McKenzie
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
April 22, 2026
·
2 min read
·
Tristan Manalac
